How MedClinic Partners Supports Retatrutide Research Programs: Supply, Documentation, and Portal Access

MedClinic Partners was built to serve the compliance needs of medical clinics and telehealth platforms that are operating at the leading edge of metabolic medicine. Our retatrutide supply program is designed specifically to support IRB research programs — with the quality documentation, cold chain integrity, and compliance infrastructure that a defensible research program requires.

Research-grade retatrutide supplied through MedClinic Partners comes with comprehensive quality documentation for every lot:

Independent third-party COA: Every lot is tested by an independent, accredited laboratory — not our own internal lab. The COA covers identity (confirming the compound is what it says it is), purity (confirming the absence of impurities above specified limits), and potency (confirming the compound is at the labeled concentration).

Sterility testing: Every injectable lot is tested for sterility — confirming the absence of bacterial and fungal contamination. This is a patient safety requirement, not a regulatory formality.

Endotoxin testing: Every injectable lot is tested for bacterial endotoxins. Endotoxin contamination in an injectable compound can cause fever, septic shock, and death. We do not ship lots that have not passed endotoxin testing.

Heavy metals and residual solvents: Testing for heavy metal contamination and residual solvents is included in our standard documentation package.

This documentation package is designed to support your compliance position in an IRB audit, a medical board investigation, or an M&A due diligence review. It is the documentation that a sophisticated buyer's healthcare counsel will ask for — and that you need to be able to produce.

Retatrutide is a peptide compound that requires refrigerated storage and cold chain shipping. MedClinic Partners ships retatrutide in validated cold chain packaging that maintains the required temperature range throughout transit, with temperature monitoring documentation included with each shipment.

Our shipping schedule is Monday through Thursday, with orders placed by 5 PM for next-day delivery. This schedule is designed to ensure that shipments arrive before the weekend — when temperature excursions are most likely to occur if a package sits in a carrier facility.

MedClinic Partners operates a provider portal that gives licensed medical providers access to our full product catalog, including research-grade retatrutide and other peptides. Portal access is available to NPI-verified providers — we verify your NPI through the CMS registry as part of the onboarding process.

Through the portal, you can:

• Place orders for research-grade retatrutide and other compounds
• Access quality documentation for each lot
• Track shipment status and cold chain monitoring data
• Access compliance resources and documentation templates

Portal access is free — we do not charge portal fees. Our revenue comes from the products we supply, not from access to the platform.

MedClinic Partners is not just a supplier. We are a compliance partner for the practices that work with us. We understand the IRB framework, the documentation requirements, and the compliance challenges that come with running a retatrutide research program. We can discuss supply arrangements that are structured to support your specific compliance needs — including documentation packages that are tailored to your IRB protocol requirements.

If you are building a retatrutide research program and want to discuss how MedClinic Partners can support it, start with portal access. The onboarding process takes minutes, and our team is available 24/7 to answer questions.